Jasmeen Merzaban
Jasmeen Merzaban
Associate Professor of Bioscience, King Abdullah University of Science and Technology
Verified email at
Cited by
Cited by
Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone
R Sackstein, JS Merzaban, DW Cain, NM Dagia, JA Spencer, CP Lin, ...
Nature medicine 14 (2), 181-187, 2008
Endosomal escape and delivery of CRISPR/Cas9 genome editing machinery enabled by nanoscale zeolitic imidazolate framework
SK Alsaiari, S Patil, M Alyami, KO Alamoudi, FA Aleisa, JS Merzaban, M Li, ...
Journal of the American Chemical Society 140 (1), 143-146, 2018
Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1
FMV Rossi, SY Corbel, JS Merzaban, DA Carlow, K Gossens, J Duenas, ...
Nature immunology 6 (6), 626-634, 2005
NMR-based metabolomics in human disease diagnosis: applications, limitations, and recommendations
AHM Emwas, RM Salek, JL Griffin, J Merzaban
Metabolomics 9, 1048-1072, 2013
Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review
AH Emwas, C Luchinat, P Turano, L Tenori, R Roy, RM Salek, D Ryan, ...
Metabolomics 11, 872-894, 2015
Cell-type-specific CRISPR/Cas9 delivery by biomimetic metal organic frameworks
MZ Alyami, SK Alsaiari, Y Li, SS Qutub, FA Aleisa, R Sougrat, ...
Journal of the American Chemical Society 142 (4), 1715-1720, 2020
Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs
KM Veerman, MJ Williams, K Uchimura, MS Singer, JS Merzaban, S Naus, ...
Nature immunology 8 (5), 532-539, 2007
CD34 and CD43 inhibit mast cell adhesion and are required for optimal mast cell reconstitution
E Drew, JS Merzaban, W Seo, HJ Ziltener, KM McNagny
Immunity 22 (1), 43-57, 2005
Not just a marker: CD34 on human hematopoietic stem/progenitor cells dominates vascular selectin binding along with CD44
DB AbuSamra, FA Aleisa, AS Al-Amoodi, HM Jalal Ahmed, CJ Chin, ...
Blood advances 1 (27), 2799-2816, 2017
Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells
JS Merzaban, MM Burdick, SZ Gadhoum, NM Dagia, JT Chu, ...
Blood, The Journal of the American Society of Hematology 118 (7), 1774-1783, 2011
Efficient fdCas9 synthetic endonuclease with improved specificity for precise genome engineering
M Aouida, A Eid, Z Ali, T Cradick, C Lee, H Deshmukh, A Atef, ...
PloS one 10 (7), e0133373, 2015
Sustained and targeted delivery of checkpoint inhibitors by metal-organic frameworks for cancer immunotherapy
SK Alsaiari, SS Qutub, S Sun, W Baslyman, M Aldehaiman, M Alyami, ...
Science advances 7 (4), eabe7174, 2021
Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis
JS Merzaban, J Imitola, SC Starossom, B Zhu, Y Wang, J Lee, AJ Ali, ...
Glycobiology 25 (12), 1392-1409, 2015
Correlative light‐electron microscopy shows RGD‐targeted ZnO nanoparticles dissolve in the intracellular environment of triple negative breast cancer cells and cause apoptosis …
BA Othman, C Greenwood, AF Abuelela, AA Bharath, S Chen, ...
Advanced Healthcare Materials 5 (11), 1310-1325, 2016
Iron-based core–shell nanowires for combinatorial drug delivery and photothermal and magnetic therapy
AI Martínez-Banderas, A Aires, M Quintanilla, JA Holguín-Lerma, ...
ACS applied materials & interfaces 11 (47), 43976-43988, 2019
Microfluidics-based super-resolution microscopy enables nanoscopic characterization of blood stem cell rolling
K AbuZineh, LI Joudeh, B Al Alwan, SM Hamdan, JS Merzaban, ...
Science Advances 4 (7), eaat5304, 2018
Magnetic core–shell nanowires as MRI contrast agents for cell tracking
AI Martínez-Banderas, A Aires, S Plaza-García, L Colás, JA Moreno, ...
Journal of nanobiotechnology 18, 1-12, 2020
CD43 is required for optimal growth inhibition of Mycobacterium tuberculosis in macrophages and in mice
AK Randhawa, HJ Ziltener, JS Merzaban, RW Stokes
The Journal of Immunology 175 (3), 1805-1812, 2005
Anti-CD44 antibodies inhibit both mTORC1 and mTORC2: a new rationale supporting CD44-induced AML differentiation therapy
SZ Gadhoum, NY Madhoun, AF Abuelela, JS Merzaban
Leukemia 30 (12), 2397-2401, 2016
Isolation of cells for selective treatment and analysis using a magnetic microfluidic chip
O Yassine, CP Gooneratne, D Abu Smara, F Li, H Mohammed, ...
Biomicrofluidics 8 (3), 2014
The system can't perform the operation now. Try again later.
Articles 1–20